The 20 aminoacyl tRNA synthetases (aaRSs) couple each amino acid to their cognate tRNAs. During evolution, 19 aaRSs expanded by acquiring novel noncatalytic appended domains, which are absent from bacteria and many lower eukaryotes but confer extracellular and nuclear functions in higher organisms. AlaRS is the single exception, with an appended C-terminal domain (C-Ala) that is conserved from prokaryotes to humans but with a wide sequence divergence. In human cells, C-Ala is also a splice variant of AlaRS. Crystal structures of two forms of human C-Ala, and small-angle X-ray scattering of AlaRS, showed that the large sequence divergence of human C-Ala reshaped C-Ala in a way that changed the global architecture of AlaRS. This reshaping removes the role of C-Ala in prokaryotes for docking tRNA and instead repurposes it to form a dimer interface presenting a DNA-binding groove. This groove cannot form with the bacterial ortholog. Direct DNA binding by human C-Ala, but not by bacterial C-Ala, was demonstrated. Thus, instead of acquiring a novel appended domain like other human aaRSs, which engendered novel functions, a new AlaRS architecture was created by diversifying a preexisting appended domain.
Results and Discussion Human C-Ala Has No Effect on Charging Activity. The sequence of C-Ala diverged widely in the evolutionary progression to humans, and this divergence raises the possibility that C-Ala may have developed to play a different role in higher organisms and, in that respect, to be akin to the appended domains of the 19 other aaRSs. To investigate this possibility, we aligned 410 AlaRS sequences from all three kingdoms of life: eukaryotes, archae, and prokaryotes (16) (Fig. 1A) . The alignment clearly showed the three well-characterized aminoacylation, editing, and C-Ala domains, and demonstrated that although the aminoacylation and editing domains are well conserved, C-Ala diverges widely (16) (Fig. 1A) . Based on the crystal structure of Archaeoglobus fulgidus C-Ala, C-Ala consists of a helical region followed by a globular domain (17) . For the various diverged C-Ala domains, we used Predictprotein (18) to predict that the helical subdomains of archaeal and bacterial C-Alas have two α-helices, whereas eukaryotes have a third, long α-helix. In contrast, the globular domains are similar across the three kingdoms (Fig. 1B) .
The helical domain of C-Ala provides contacts for dimerization of A. fulgidus AlaRS (17) and for docking the outside corner of the L-shaped tRNA to the enzyme (19) . Consistently, although the C-Ala segment is not essential for aminoacylation, it enhances catalytic efficiency (16, (20) (21) (22) . Given the low similarity of human and bacterial or archaeal C-Ala, we compared the aminoacylation activity of full-length and C-Ala-truncated human AlaRS (Hs AlaRS and Hs AlaRS-ΔC-Ala) with their Escherichia coli and A. fulgidus orthologs. Consistent with previous studies (16, 20, 21) , Ec or Af AlaRS-ΔC-Ala exhibited sharply reduced activity relative to full-length AlaRS, but in contrast, deletion of C-Ala did not
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Here we present an exception that supports the rule that the 20 human tRNA synthetases acquired new architectures to expand their functions during evolution. The new features are associated with novel, appended domains that are absent in prokaryotes and retained by their many splice variants. Alanyl-tRNA synthetase (AlaRS) is the single example that has a prototypical appended domain-C-Ala-even in prokaryotes, which is spliced out in humans. X-ray structural, small-angle X-ray scattering, and functional analysis showed that human C-Ala lost its prokaryotic tRNA functional role and instead was reshaped into a nuclear DNAbinding protein. Thus, we report another paradigm for tRNA synthetase acquisition of a novel function, namely, repurposing a preexisting domain rather than addition of a new one. significantly affect the activity of Hs AlaRS (Fig. 1 C-E) . Thus, Hs C-Ala is completely dispensable for aminoacylation.
Crystal Structure of Human C-Ala. Given Hs C-Ala's wide sequence divergence and lack of role in aminoacylation, we speculated that its structure is distinct from its prokaryote ortholog. Based on its dispensability for aminoacylation, we hypothesized that Hs C-Ala lacks the contact between C-Ala and the tRNA elbow region that is seen in the bacterial enzyme. Because C-Ala also contributes part of the α2 dimerization interface of bacterial AlaRS, and given the previously noted α2 dimeric quaternary structure of Hs AlaRS, efforts were made to understand whether Hs C-Ala formed a dimer. Based on secondary structure predictions and the previously solved archaeal C-Ala structure (17), we made a C-Ala construct consisting of the C-terminal 757-968 amino acids of human AlaRS. We purified the recombinant protein from the soluble fraction of the bacterial lysate and, during gel filtration, observed only a monomeric form of the recombinant human C-Ala protein in buffer containing 1 mM DTT (Fig. S1B ). However, in addition to the monomer, a dimeric form appeared with buffer containing oxidative agents, such as 1 mM glutathione disulfide (GSSG) (Fig. S1B ). After screening through a variety of conditions, we obtained two different crystal forms, each of which was specific to a particular condition (Fig. S1A ). One of these crystal forms harbored the monomer and was obtained using 0.1 M Tris pH 8.5 and 25% (wt/vol) polyethylene glycol 3350, whereas the other captured a dimer using 0.2 M ammonium acetate, 0.1 M Tris pH 8.5, and 25% (wt/vol) polyethylene glycol 3350. The structure of the monomer was determined from a selenomethionine-substituted crystal ( Fig. 2A ). This crystal (space group P2 1 , with unit-cell parameters a = 41.645, b = 38.449, and c = 62.471Å) diffracted up to 2.0 Å with an asymmetric unit containing one molecule of C-Ala, and a refined model R work factor of 21.46% and R free factor of 25.76%. The dimer-containing crystal (space group C222 1 , with unit-cell parameters a = 90.829, b = 136.141, and c = 59.077Å) had one molecule of C-Ala in the asymmetric unit, with a refined model R work factor of 20.78% and and R free factor of 25.45% (Fig. 2B) . Details of the structure determination are provided in SI Methods and Table S1 .
As expected, the monomer of Hs C-Ala consists of a helical subdomain and a separate globular subdomain, similar to the A. fulgidus C-Ala. The helical subdomain contains three α-helices, consistent with the secondary structure predictions, whereas the globular subdomain comprises a five-stranded β-sheet and four α-helices (Figs. 1B and 2A). Interestingly, in the dimeric form, a disulfide bridge was formed between the helical subdomain of one molecule and the globular subdomain of the other molecule ( Fig. 2 B and C and Fig. S1C ).
The root-mean-squared deviation (rmsd) of the Cα positions between the monomer and dimer is ∼1.5 Å for the superimposed helical subdomains and 0.6 Å for the globular subdomains (Fig.  S1D) . When the two structures were superimposed, we observed that Asn944 and Val945 in the dimer forced Cys947 out of the globular subdomain to contact Cys773 from the other molecule. In contrast, in the monomer, Cys773 and Cys947 extend in opposite directions and cannot make a disulfide bond (Fig. S1E) .
Comparison of Human C-Ala with A. fulgidus C-Ala. As noted above, dimeric A. fulgidus C-Ala contains a long helical domain and a separate globular domain (Figs. 1B and 2D ). The A. fulgidus C-Ala dimer is formed through a helix-loop-helix zipper (HLHZ) between the helical domains of the two partners (17) . The structure of this dimer is unchanged in the context of the full-length dimeric A. fulgidus AlaRS (17, 19) (Fig. S2) . However, after binding to one tRNA molecule, the globular domain of the full-length A. fulgidus AlaRS exhibits a conformational shift toward tRNA to contact the elbow region (Fig. S2) . A comparison of human and archaeal C-Ala dimers shows that whereas archaeal C-Ala has a parallel dimer organization relying on HLHZ interactions, the Hs C-Ala has a "head-to-tail" or antiparallel organization, with the globular domain of one monomer interacting with the helical domain of the other monomer and vice versa ( Fig. 2 B and D) .
Comparison of the monomers shows that whereas A. fulgidus C-Ala has two α-helices in the helical domain, C-Ala has an additional α-helix at the C-terminal end of the helical domain (Fig. 2E) . Although these monomers' overall structures are similar, they did not superimpose well. When superimposing only the globular domains, the rmsd of Cα positions between human C-Ala and the C-Ala portion of A. fulgidus AlaRS is ∼5.8 Å, which means that the two domains are not well conserved as structures; however, we found that the glycine-rich or "GG" motifs (the GKGGG segment in human C-Ala and GSGGG segment in A. fulgidus C-Ala) are highly conserved (Fig. 2F) . A comparison of the human and A. fulgidus C-Ala structures clearly shows that a significant sequence divergence between the two species results in completely distinct architectures. Thus, our two crystal structures, which are the first of the eukaryotic AlaRS C-Ala domain, reveal a completely different dimerization interface that results in an antiparallel organization. To investigate the evolutionary conservation of amino acids within C-Ala, we used ConSurf (23, 24) to determine the importance of each amino acid within the protein. We used both human and A. fulgidus structures as templates and compared them with 150 sequences of all homologous organisms displaying a sequence identity between 30% and 90%. For both structures, the region with the highest sequence conservation score is the GG motif that we previously identified in the globular domain ( Fig. 2 G and H) . Similarly, for both human and A. fulgidus templates, we found that all residues present at the dimer interface are highly variable and have the lowest conservation scores (1 and 2 on the scale) ( Fig. 2 G and H) . This low conservation explains how the HLHZ dimerization mode was lost during evolution, allowing the Hs C-Ala to form a structurally distinct dimer that may be associated with novel functions. Interestingly, within the eukaryote-specific α3 helix, a highly conserved motif occurs that contains structurally contiguous positively charged residues (K812, R816, K823, K824, R831, K834, and K846) ( Fig. 2H and Fig. S1F ). It is tempting to speculate that this highly conserved motif is involved specific functions in higher organisms.
Comparison of Human AlaRS with A. fulgidus AlaRS. To confirm that this distinct dimerization extends to the full-length AlaRS, we performed small-angle X-ray scattering (SAXS) on both the monomeric and dimeric forms of the full-length human AlaRS that was isolated from gel filtration (Fig. S3A) . The shapes of the SAXS profiles and the corresponding Guinier plots obtained for both samples are independent of protein concentration, indicating the absence of significant aggregation (Fig. 3A) . Guinier analysis in the low-q region gives radius of gyration (R g ) values of 40.2 Å for the monomeric form and 63.8 Å for the dimeric form ( Fig. 3 A  and C) . The molecular masses calculated from the Porod volume are in agreement with what we expected for the monomeric form (105.8 kDa) and the dimeric form (242.5 kDa) of the protein (Fig. 3C) .
We next used DAMMIF to perform ab initio shape reconstruction from the SAXS data. Several series of independent runs were carried out with no forced symmetry. All models were reproducible, with an average normalized spatial discrepancy (NSD) <1.0, indicating structurally similar solutions. Then the models resulting from 20 independent DAMMIF runs were superimposed and averaged using the DAMAVER suite to obtain a final averaged and filtered model (Fig. 3B) .
We also generated a model of the full-length human AlaRS using the available human crystal structures for the aminoacylation and C-Ala domains, and also for the editing domain based on its structure in the A. fulgidus enzyme (25) . The dimeric model was generated using the dimer interface of the crystal structure of the human C-Ala described herein. The resulting models for both the monomeric and dimeric human C-Ala fit well within the calculated SAXS envelopes (Fig. 3B) . Importantly, a dimeric model based on the archaeal enzyme's dimerization interface cannot fit into the dimeric envelope, which clearly highlights the difference in the dimeric interface between human and archaeal orthologs.
We extracted the SAXS profile of A. fulgidus AlaRS from the previously solved crystal structure, and compared it with the experimental SAXS profile recorded for the Hs AlaRS for both monomer and dimer forms. The overall shapes of the two AlaRS monomers are quite similar (Fig. 3D) , and superposition of the SAXS profile shows a good superimposition in the low-and medium-q value regions (Fig. 3D, boxes 1 and 2, respectively) . The SAXS profile in the low-q region characterizes the global shape and size of the particle analyzed, whereas the medium-q region is related to local conformational differences. In the case of the dimeric proteins, the envelopes for the human AlaRS and the A. fulgidus AlaRS are clearly distinct, in agreement with a completely different dimerization interface between the AlaRSs of the two organisms. Moreover, superimposition of the SAXS profile clearly confirmed this difference, with a large deviation in both low-and medium-q value regions, thus supporting the different shapes of the proteins in solution.
Human C-Ala Binds DNA. Our observations led us to wonder why the human AlaRS evolved to form a new dimerization mode. Charging assays with both the monomer and dimer forms of human AlaRS revealed that this new dimerization mode does not affect tRNA binding or charging activity (Fig. S3B) . Kinetic analysis showed that k cat was unchanged for human AlaRS vs. AlaRS-ΔC-Ala, whereas the K m for tRNA was nominally improved (an ∼30% decrease) by the presence of the C-Ala domain (Table S2 ). In contrast, the effect of C-Ala is dramatic for the E. coli and A. fulgidus enzymes (16, 22) . Therefore, it is likely that human C-Ala has little or no contact with bound tRNA, suggesting that it evolved to gain other functions. From the crystal structure of the human C-Ala dimer, a disulfide bond is formed across the dimer interface between Cys773 and Cys947 (the numbering system of AlaRS). Whereas Cys947 was acquired in evolution by zebrafish and mouse and retained by human C-Ala, only Hs C-Ala added Cys773. Thus, under oxidative conditions, the C-Ala dimer should be further stabilized and become the dominant form. To obtain clues about the function of the Hs C-Ala dimer, we analyzed the surface charge of our crystal structure. Interestingly, one face of the C-Ala dimer had major positive patches, whereas the other face was rather neutral (Fig. 4A) . Residues R793, K820, K823, K824, R831, K834, K839, and K846 from the helical domain combined with K869, K876, K898, K930, and K943 from the globular domain to form a positively charged groove that closely recapitulates a DNA-binding groove (Fig. 4A) . Moreover, our conservation analysis with ConSurf showed that most of these residues (K823, K824, R831, K834, K846, K869, K876, K898, and K930) had a high conservation score (8 or 9) in the eukaryotic-specific helical motif ( Fig. 2H and Fig. S1F ).
To predict how DNA would bind to Hs C-Ala, we used the Discovery Studio ZDOCK program (26), a rigid-body proteindocking algorithm that uses a fast Fourier transform algorithm to speed search in translational space, to create a DNA-binding model (Fig. 4B ). In this model, DNA binds to the human C-Ala dimer through the positive charges on surface of the dimer interface, with an unobstructed fit into the DNA-binding groove.
Although the A. fulgidus C-Ala dimer showed some positive patches on the surface, it did not exhibit any region that would likely form a DNA-binding groove (Fig. 4C) . Given the knowledge that E. coli AlaRS can bind to and regulate expression of its own gene (27) , we tested the DNA-binding activities of both Hs C-Ala and Ec C-Ala (Fig. 4D ) through a DNA cellulose-binding assay. We incubated 2 μg of Hs C-Ala and 80 μg of Ec C-Ala with DNA cellulose and evaluated whether the proteins could be pulled down with the DNA cellulose. The proteins that bound to DNA cellulose were eluted in SDS sample buffer and run on an SDS/PAGE gel. The amount of protein bound to DNA was determined by silver staining. Although higher concentrations of Ec C-Ala were used, Ec C-Ala did not show any DNA binding, whereas Hs C-Ala showed robust DNA binding.
We also compared the DNA binding of Hs AlaRS (1 μg) and Hs C-Ala (1 μg), with Hs GlyRS (1 μg) used as a control (Fig.  4E) . We determined the amount of protein bound to DNA through Western blot analysis with a His tag antibody. Whereas Hs AlaRS showed no binding to either cellulose (control) or DNA cellulose, Hs C-Ala showed strong binding to DNA cellulose, but not to cellulose alone. This result demonstrates that Hs C-Ala may have to be separated from full-length protein to have strong DNA-binding activities. The sequence-specificity of this DNA binding activity is under investigation. Because of its small size (23 kDa), we expected Hs C-Ala to enter the nucleus. This expectation was confirmed (Fig. 4F) . When we initiated the present study, AlaRS appeared to be an isolated example in which an appended domain was not introduced during eukaryote evolution to change the overall synthetase architecture and thereby introduce a new function. Here we show that AlaRS followed a different evolutionary path, by exploiting what appears to be a highly adaptable structure of a preexisting appended domain (C-Ala). This evolution resulted in a distinct dimerization mode for C-Ala, which in turn also changed the quaternary shape of Hs AlaRS (Fig. 4G) . We raise the possibility that the change in
